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Background: We investigated Polygonum hydropiper L. (P. hydropiper) for phenolic contents, antioxidant,
anticholinesterase activities, in an attempt to rationalize its use in neurological disorders.
Methods: Plant crude extract (Ph.Cr), its subsequent fractions: n-hexane (Ph.Hex), chloroform (Ph.Chf), ethyl acetate
(Ph.EtAc), n-Butanol (Ph.Bt), aqueous (Ph.Aq) and saponins (Ph.Sp) were evaluated for 1,1-diphenyl,2-picrylhydrazyl
(DPPH), 2,2-azinobis[3-ethylbenzthiazoline]-6-sulfonic acid (ABTS) free radical scavenging potential. Further,
acetylcholinesterase (AChE) & butyrylcholinesterase (BChE) inhibitory activities were performed using Ellman's
assay. Moreover, total phenolic contents of plant extracts were determined and expressed in mg of gallic acid
equivalent per gram of dry sample (mg GAE/g dry weight).
Results: Among different fractions, Ph.Cr (90.82), Ph.Chf (178.16), Ph.EtAc (203.44) and Ph.Bt (153.61) exhibited
high phenolic contents. All fractions showed concentration dependent DPPH scavenging activity, with Ph.EtAc
71.33% (IC50 15 μg/ml), Ph.Bt 71.40% (IC50 3 μg/ml) and Ph.Sp 71.40% (IC50 35 μg/ml) were most potent. The
plant extracts exhibited high ABTS scavenging ability i.e. Ph.Bt (91.03%), Ph.EtAc (90.56%), Ph.Sp (90.84%), Ph.Aq
(90.56%) with IC50 < 0.01 μg/ml. All fractions showed moderate to high AChE inhibitory activity as; Ph.Cr, 86.87%
(IC50 330 μg/ml), Ph.Hex, 87.49% (IC50 35 μg/ml), Ph.Chf, 84.76% (IC50 55 μg/ml), Ph.Sp, 87.58% (IC50 108 μg/ml)
and Ph.EtAc 79.95% (IC50 310 μg/ml) at 1 mg/ml). Furthermore the BChE inhibitory activity was most prominent
in Ph.Hex 90.30% (IC50 40 μg/ml), Ph.Chf 85.94% (IC50 215 μg/ml), Ph.Aq 87.62% (IC50 3 μg/ml) and Ph.EtAc
81.01% (IC50 395 μg/ml) fractions.
Conclusions: In this study, for the first time, we determined phenolic contents, isolated crude saponins, investigated
antioxidant and anticholinestrase potential of P. hydropiper extracts. The results indicate that P. hydropiper is enriched
with potent bioactive compounds and warrant further investigation by isolation and structural elucidation to find novel
and affordable compounds for the treatment of various neurological disorders.
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Medicinal plants are nature’s gift and are necessary for
disease-free & healthy life of human beings. Since an-
cient times, plants have been employed for prevention
and treatment of a variety of ailments. There has been a
great revival in the use of herbal remedies particularly in
last decades. According to World Health Organization
(WHO), approximately eighty percent of the world popula-
tion relies on medicinal plants to meet their primary health
care [1]. P. hydropiper, also called Smartweed (family
polygonaceae), has a long history of herbal use, equally in
Eastern & Western herbal medicine. Domestically, it is
used as anti-inflammatory, carminative, astringent, diur-
etic, CNS stimulant, diaphoretic, stomachic, styptic, in
bleeding and in diarrhea [2]. The plant is enriched with
rutin which strengthens fragile blood vessels and helps in
the prevention of bleeding [3]. Traditionally, the whole
plant decoction is used to treat an extensive range of ail-
ments like dyspepsia, diarrhea, menorrhagia, hemorrhoids
and skin itching [4]. Recently antioxidant flavonoids have
been isolated from leaves of P. hydropiper [5]. Other spe-
cies of polygonaceae family have been reported for their ef-
fectiveness in cerebral ischemia [6], parkinson's disease [7]
and neuroprotective effects [8].
Free radicals are implicated in the progression of a var-
iety of disorders in humans including central nervous
system injury, arthritis, atherosclerosis, ischemic heart
diseases, gastritis, cancer and reperfusion injury of many
tissues [9,10]. Free radicals from environmental pollut-
ants, chemical agents, radiations, toxins, spicy and deep
fried foods cause reduction of immune system antioxi-
dants, alter gene expression along with induction of ab-
normal proteins. Free radicals are generated in living
systems during oxidation process. To counteract oxida-
tive stress, catalase and hydroperoxidase enzymes in
human body convert hydrogen peroxide and hydro-
peroxides to nonradical forms and hence work as natural
antioxidants. Thus, due to depletion of human immune
system, natural antioxidants as free radical scavengers
may be necessary [11,12]. Presently available synthetic
antioxidants including butylated hydroxy toluene (BHT),
butylated hydroxy anisole (BHA), gallic acid esters and
tertiary butylated hydroquinon have been alleged to be
associated with negative health consequences. Hence,
their use is restricted and there is a tendency to substi-
tute them with natural antioxidants [13]. Numerous re-
ports on the antioxidant and radical-scavenging activities
of crude extracts and pure natural compounds have been
published [10,14]. Among the antioxidant compounds,
significant attention has been given to phenolic com-
pounds and flavonoids. Phenolic compounds, due to the
existence of the conjugated ring structures and hydroxyl
groups, have the potential to function as antioxidants by
scavenging the free radicals that are involved in oxidativeprocesses via hydrogenation or complexation with oxidiz-
ing species [15].
Acetylcholinesterase (AChE) and butyrylesterase (BChE)
are useful targets for the development of novel and mech-
anism based inhibitors, due to its role in the breakdown of
acetylcholine (ACh) neurotransmitter. Inhibitors of AChE
and BChE enzymes are the most valuable approaches to
treat neurological diseases including Alzheimer's disease
(AD) [16] and possible beneficial applications in the treat-
ment of Parkinson's disease, ataxia and dementia [17]. AD
is a persistent neurological disorder frequently associated
with memory impairment, behavioral turbulence, cogni-
tive dysfunction and imperfection in routine life activities
[18,19]. This disease results from malfunctioning of differ-
ent biochemical pathways resulting in a significant decline
in ACh amount [20]. ACh is involved in signal transmis-
sion in the synapse and its pharmacological action is ter-
minated primarily by AChE and secondly by BChE [21].
Therefore inhibitors of these metabolizing enzymes have
become the important alternatives in treatment of AD and
other neurological diseases. Conversely, presently available
drugs are associated with serious side effects including
hepatotoxicity [22] and are only effective in mild type of
AD [23]. Consequently, it is necessary to embark new,
safe and effective drug candidates. Plants are potential
sources of novel active compounds and have a long his-
tory of therapeutic use since the beginning of human era.
Galanthamine, an anticholinestrase alkaloid isolated from
snowdrop, has been recently approved for the treatment of
AD [24]. Research has been focused on the biological ef-
fects of plants which have been traditionally used as cho-
linesterase inhibitors in-vitro as well as in-vivo [24,25].
This study is focused on preliminary anticholinestrase and
antioxidant potential of P. hydropiper.
Methods
Plant Collection, Extraction and Fractionation
P. hydropiper whole plant was collected from Talash
Valley, Khyber Pakhtoonkhwa, Pakistan in July, 2013.
The plant was identified by botanical taxonomist at
Arid agriculture University, Rawalpindi, Pakistan and a
sample was deposited at the herbarium, University of
Malakand Chakdara (Dir), Pakistan with voucher no
(H.UOM.BG.107). Plant material was cleansed with dis-
tilled water and was shade dried for 15 days. Thereafter, it
was coarsely crushed using cutter mill. The powder mater-
ial (4.5 kg) was soaked in 80% methanol (22 L) for 10 days
with frequent shaking. Extraction with methanol was
repeated three times, added to original extract and fil-
tered through muslin cloth and then through filter [26].
The filtrate was concentrated using rotary evaporator
(Heidolph Laborota 4000, Schwabach, Germany) under
reduced pressure at 40°C resulting in 290 g (6.44%) of
dark brown colored semisolid mass. Crude methanolic
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in 500 ml of distilled water and consequently partitioned
with n-hexane (3 × 500 ml), chloroform (3 × 500 ml),
ethyl acetate (3 × 500 ml), n-butanol (3 × 500 ml) and
aqueous (3 × 500 ml), using separating funnels. Finally,
68g (27.2%) Ph.Hex, 27g (10.8%) Ph.Chf, 13g (5.2%) Ph.
EtAc, 11 g (4.4%) Ph.Bt & 37 g (14.8%) Ph.Aq fractions
were obtained.
Extraction of crude saponins
A portion of powdered plant material, weighing 60 g,
was transferred to a conical flask and was soaked with
100 ml of 20% ethanol. The mixture was heated for 4 h
at a temperature of 55°C using water bath and constant
shaking. Thereafter, it was filtered and was again ex-
tracted with 200 ml of 20% ethanol. Volume of the li-
quid extract was reduced to 40 ml using water bath
and transferred it to a separating funnel. Diethyl ether
(20 ml) was added to it with vigorous shaking until two
layers were formed. Organic layer was discarded, whereas
60 ml of n-butanol was added to aqueous fraction. The
combined aqueous-butanol mixture was washed with 5%
NaCl solution two times. Finally solvents were evapo-
rated using water bath to get saponins (9 g) with a per-
cent yield of 15% [27].
Chemical and Drugs
DPPH (CAS 1898-66-4 Sigma Aldrich CHEMIE GmbH
USA), ABTS (CAS 30931-67-0 Sigma Aldrich USA),
K2S2O4 (Riedel-de Haen Germany), Gallic acid (CAS
149-91-7 GmbH USA) and Folin Ciocalteu reagent (FCR)
was purchased from Merck Co. (Germany). Enzymes in-
cluding AChE Electric eel (type-VI-S, CAS 9000-81-1
Sigma-Aldrich GmbH USA), BChE equine serum Ly-
ophilized (CAS 9001-08-5 Sigma-Aldrich GmbH USA),
substrates acetylthiocholine iodide (CAS1866-15-5 Sigma-
Aldrich UK), butyrylthiocholine Iodide CAS 2494-56-6
Sigma-Aldrich Switzerland), DTNB 5,5-dithio-bis-nitro-
benzoic acid (CAS 69-78-3 Sigma-Aldrich Germany),
Galanthamine hydrobromide Lycoris Sp. (CAS 1953-04-4
Sigma-Aldrich France) were used for enzyme inhibition
study. For preparation of buffer, di-potassium hydrogen
phosphate (K2HPO4), Potassium di-hydrogen phosphate
(KH2PO4), potassium hydroxide used were of extra pure
analytical grade.
Total phenolic contents
Total phenolic contents of the fractions were investi-
gated using procedure adopted by Kim et al., [28]. One
ml from each concentration of the plant extract was
added to 9 ml distilled water followed by addition of
1 ml FCR with vigorous shaking. After five minutes,
10 ml of 7% Na2CO3 solution was added to the tube and
mixed properly. Distilled water (25 ml) was added to thismixture and analyzed after 90 minutes using spectro-
photometer (Thermo electron corporation, USA) at
750 nm. Finally gallic acid (97.5% pure) standard curve was
employed to quantify total phenolic contents and were
expressed as mg equivalent of gallic acid.
DPPH radical scavenging assay
Free radical scavenging ability of the samples, based on
the scavenging activity of 1,1-diphenyl,2-picrylhydrazyl
(DPPH) free radical, was evaluated using the procedure
described previously [29]. Different dilutions (125, 250,
500 and 1000 μg/ml) of plant extract (0.1 ml) were
added to 0.004% methanolic solution of DPPH. After
30 minutes, absorbance was determined at 517 nm using
UV spectrophotometer. Ascorbic acid was used as posi-
tive control, percent scavenging activity was calcu-
lated as; [(A0 - A1)/A0] × 100, where A0 represent
absorbance of control and A1 is the absorbance of
the plant extracts. Each experiment was done in trip-
licate and inhibition graphs were constructed using
the GraphPad prism program (GraphPAD, San Diego,
California, USA) and median inhibitory concentrations
IC50 values were determined.
ABTS free radical scavenging assay
The antioxidant potential of P. hydropiper was also
evaluated using 2, 2-azinobis [3-ethylbenzthiazoline]-
6-sulfonic acid (ABTS) [30]. The assay is based on
the capacity of antioxidants to scavenge ABTS radical
cation causing a reduction in absorbance at 734 nm.
briefly, ABTS 7 mM and potassium persulphate (K2S2O4)
2.45 mM solutions were prepared and mixed. The result-
ant mixture was stored in dark at room temperature for
12-16 h to get dark colored solution containing ABTS
radical cations. Prior to use, ABTS radical cation solution
was diluted with Phosphate buffer (0.01 M) pH 7.4, to ad-
just an absorbance value of 0.70 at 734 nm. Radical scav-
enging ability of the fractions was analyzed by mixing
300 μl of test sample with 3.0 ml of ABTS solution in
cuvette. The reduction in absorbance was measured
spectrophotometrically after one minute of mixing the
solutions and continued for six min. Ascorbic acid was
used as positive control. The assay was repeated in trip-
licate and percentage inhibition was calculated using
formula:
% scavenging effect ¼ control absorbance
− sample absorbance
=control absorbance 100
The antioxidant effect was expressed in terms of per-
cent inhibition and as EC50 (Extract concentration re-
quired for 50% reduction of ABTS radicals).
































Figure 1 Total phenolic content in different fractions of
P. hydropiper. Activity expressed as mg GAE/g of sample
(mean ± SEM n = 3).
Ayaz et al. BMC Complementary and Alternative Medicine 2014, 14:145 Page 4 of 9
http://www.biomedcentral.com/1472-6882/14/145Anticholinesterase assays
AChE from Electric eel and BChE from equine serum
were used to explore the enzymes inhibitory potential of
Ph.Cr of P. hydropiper, its subsequent fractions and Ph.
Sp using Ellman's assay [31,32]. The assay is based on
the hydrolysis of acetylthiocholine iodide or butyr-
ylthiocholine iodide by the respective enzymes and
the formation of 5-thio-2-nitrobenzoate anion followed
by complexation with DTNB to give yellow color com-
pound which is detected with spectrophotometer beside
the reaction time.
Preparation of solutions
Ph.Cr and subsequent fractions were dissolved in phos-
phate buffer (0.1 M) in concentrations ranging from
125-1000 μg/ml. For the preparation of 0.1 M and
8.0 ± 0.1 pH phosphate buffer solution, K2HPO4 (17.4 g/L)
and KH2PO4 (13.6 g/L) were prepared and were mixed
in 94% and 6% ratio respectively. Finally, potassium
hydroxide was used to adjust PH. AChE (518U/mg
solid) and BChE (7-16U/mg) were diluted in freshly
prepared buffer pH 8.0 until final concentrations of
0.03U/ml and 0.01U/ml were obtained. Solutions of
DTNB (0.0002273 M), ATchI and BTchI (0.0005 M)
were prepared in distilled water and were kept in eppen-
dorf caps in the refrigerator at 8°C. Galanthamine (Positive
control) was dissolved in methanol and the aforemen-
tioned dilutions were prepared.
Spectroscopic analysis
For each assay, an enzyme solution of 5 μl was added to
the cuvette followed by addition of plant extract solution
(205 μl), and finally DTNB reagent (5 μl). The solution
mixture was maintained at 30°C for 15 min using water
bath with subsequent addition of substrate solution
(5 μl) was added. A double beam spectrophotometer
(Thermo electron corporation USA) was used to meas-
ure the absorbance at 412 nm. Negative control con-
tained all components apart from the plant extracts,
whereas positive control galanthamine (10 μg/ml) was
used in the assay as standard cholinesterase inhibitor.
The absorbances along with the reaction time were
taken for four minutes at 30°C. The experiments were
performed in triplicate. The enzyme activity and enzyme
inhibition by control and tested samples were calcu-
lated from the rate of absorption with change in time
(V = ΔAbs /Δt) as follow;
Enzyme inhibition (%) = 100 - percent enzyme activity
Enzyme activity (%) = 100 × V/Vmax where (Vmax) is
enzyme activity in the absence of inhibitor drug.
Estimation of IC50 values
Concentrations of the plant extracts which inhibited
substrate hydrolysis (AChE and BChE) by 50% (IC50).Radical scavenging ability was calculated by a linear re-
gression analysis among the percent inhibition against
the extract concentrations via Excel program.
Statistical data analysis
All the assays were repeated in triplicate and vales were
expressed as means ± S.E.M. Significance between anti-
oxidant activity and plant extracts were analyzed using
Mann–Whitney U test. Group comparison was done using
Student’s t-test. The P values less than 0.05 were consid-
ered as statistically significant.
Results
Total phenolic content
The extraction yield of phenolics (mg GAE/g of sample)
in different fractions of the plant extracts are sum-
marized in Figure 1. Ph.EtAc and Ph.Chf exhibited
high phenolic contents as compared to other fractions.
The concentration of phenolics among different frac-
tions were in an ascending order of Ph.EtAc > Ph.Chf >
Ph.Bt > Ph.Cr > Ph.Aq > Ph.Hex.
DPPH Free radical scavenging potential
In the DPPH free radical scavenging assay, all fractions
showed concentration dependent inhibition of the free
radicals as shown in Figure 2. Among different frac-
tions, Ph.EtAc, Ph.Bt and Ph.Chf showed highest activ-
ity which can be attributed to their high phenolic
contents. Ph.Bt, Ph.Chf and Ph.EtAc fractions were
most potent with IC50 of 3, 10 and 15 μg/ml respect-
ively. The DPPH free radical scavenging potential of
the tested fractions were in an ascending order of Ph.
EtAc > Ph.Bt > Ph.Chf > Ph.Sp > Ph.Cr > Ph.Hex > Ph.Aq.
In comparison to positive control, Ph.Cr, Ph.Hex, Ph.
Chf, Ph.Aq and Ph.Sp percent inhibitions were significantly




































Figure 2 Antioxidant assay of plant extracts using DPPH assay. Values represent% radical scavenging (mean ± SEM) of three replicates.
Values significantly different as compare to positive control, *P < 0.05, **P < 0.01, ***P < 0.001.
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(1000 μg/ml).
ABTS Free radical scavenging assay
Results of ABTS free radical scavenging assay are given
in Table 1. Plant extracts revealed high ABTS free rad-
ical scavenging activity in comparison to DPPH. Among
different fractions, Ph.Bt, Ph.EtAc, Ph.Aq, Ph.Sp revealed
highest ABTS scavenging activity causing 91.03, 90.65,
90.56 and 90.84% inhibition of free radicals respectively.
The scavenging activity of these fractions were compar-
able with the positive control ascorbic acid with IC50
values of 0.01 μg/ml.
Acetylcholinesterase Inhibition assay
Among different fractions of P. hydropiper, Ph.Sp, Ph.
Hex and Ph.Cr fractions showed strongest activity caus-
ing 87.58, 87.49 and 86.87% inhibition of AChE. All frac-
tions were effective in concentration dependent manner
as summarized in Table 2. Ph.Hex, Ph.Chf and Ph.Sp
were most potent displaying median inhibitory values
(IC50) of 35, 55 and 100 μg/ml. Whereas the IC50 value
for positive control galanthamine was 0.1 μg/ml. The
AChE inhibitory activity of the tested fractions were in
an ascending order of Ph.Sp > Ph.Hex > Ph.Cr > Ph.Chf >
Ph.EtAc > Ph.Bt > Ph.Aq.
Butyrylcholinesterase inhibition assay
BChE inhibitory activity was most prominent for, Ph.
Hex, Ph.Aq, Ph.Chf and Ph.EtAc fractions at 1 mg/ml
concentration. Results are given in Table 3. Ph.Hex, Ph.
Aq and Ph.Chf exhibited 90.30, 87.62 and 85.94% inhib-
ition of BChE which is comparable to positive cotrol gal-
antamine causing 96% enzyme inhibition at the same
concentration (1 mg/ml). Whereas Ph.Aq and Ph.Hex
were more potent with IC50 values of 3 and 40 μg/ml.Discussion
Discovery and development of new antioxidant drugs
is among the most exciting areas of pharmacological
research. Oxygen is a vital element of aerobic life, but
under certain conditions it can seriously influence our
health by formation of reactive oxygen species (free
radicals) leading to some potentially dangerous dis-
eases, like coronary heart disease, diabetes, atheroscler-
osis, neurodegenerative disorders (AD & Dementia),
cancer, immune-suppression, ageing and ulcer [33,34].
Most common free radicals include hydroxyl, nitric
oxide, superoxide & lipid peroxyl, whereas non-free
radicals primarily include singlet oxygen and hydrogen
peroxide [35]. Nevertheless, approximately all living or-
ganisms are protected from free radicals attack by
defense system, such as a protective antioxidant system
that diminish the rate of free radical formation along with
another system which create chain-breaking antioxidants
to scavenge & stabilize free radicals. However, when the
rate of free radical generation exceeds the capacity of
defense mechanisms, extensive tissue injury results [36].
Consequently, drugs with free radical scavenging abilities
are useful for the prevention and therapy of these dis-
eases [37]. Antioxidant compounds are known to show
their biochemical effects via several mechanisms, includ-
ing hindrance of chain initiation, chelation of metal ions,
breakdown of peroxides, sustained hydrogen abstraction,
reductive ability and radical scavenging. Hence, numer-
ous methods are proposed to assess the antioxidant
activity. DPPH is an extensively used model system
to evaluate the free radical scavenging potential of
drugs [38]. DPPH radicals are scavenged by antioxi-
dants through the donation of hydrogen, thus forming
reduced DPPH-H, which change the color from purple
to yellow following reduction and is quantified by ana-
lyzing absorbance at wavelength 517 nm [39]. The ABTS
Table 1 ABTS free Radical scavenging assay of plant







Ph.Cr 1000 88.58 ± 1.12 < 0.01
500 87.65 ± 1.34
250 84.31 ± 2.15
125 77.56 ± 1.73*
1000 88.44 ± 0.58
500 87.90 ± 0.96
Ph.Hex 250 86.28 ± 2.19 < 0.01
125 81.77 ± 1.24
1000 89.76 ± 0.71
500 87.65 ± 1.32
Ph.Chf 250 84.23 ± 1.83 < 0.01
125 79.10 ± 0.90*
1000 90.56 ± 1.06
500 87.42 ± 0.43
Ph.EtAc 250 86.42 ± 0.46 < 0.01
125 80.90 ± 1.55
1000 91.03 ± 0.35
500 90.08 ± 0.47
Ph.Bt 250 87.91 ± 0.88 < 0.01
125 83.80 ± 1.50
1000 90.56 ± 1.06
500 90.08 ± 0.47
Ph.Aq 250 87.91 ± 0.88 < 0.01
125 83.80 ± 1.50
1000 90.84 ± 0.30
500 88.72 ± 1.01
Ph.Sp 250 87.94 ± 1.13 < 0.01
125 79.80 ± 0.90*
1000 87.90 ± 0.96
500 83.08 ± 0.47
Ascorbic acid 250 79.85 ± 2.24 < 0.1
125 77.40 ± 0.20
Values significantly different as compare to positive control, *P < 0.05.
Values expressed as Percent inhibition (Mean ± SEM of n = 3) and IC50.







Ph.Cr 1000 86.87 ± 1.27 330
500 80.62 ± 1.67**
250 31.31 ± 0.58***
125 27. 22 ± 1.28***
Ph.Hex 1000 87.49 ± 0.60 35
500 76.28 ± 1.94**
250 70.08 ± 1.04***
125 65.37 ± 0.56***
Ph.Chf 1000 84.76 ± 0.61 55
500 81.36 ± 1.31**
250 66.27 ± 1.06***
125 61.17 ± 1.30***
Ph.EtAc 1000 79.95 ± 2.01** 310
500 58.89 ± 4.82***
250 46.22 ± 1.28***
125 40.51 ± 0.54***
Ph.Bt 1000 75.52 ± 3.28** 240
500 55.59 ± 3.28***
250 50.83 ± 1.21***
125 45.87 ± 0.85***
Ph.Aq 1000 67.60 ± 1.63*** 100
500 64.42 ± 1.89***
250 58.25 ± 1.40***
125 51.10 ± 0.60***
Ph.Sp 1000 87.58 ± 0.63 108
500 86.61 ± 0.43
250 60.93 ± 0.67***
125 53.65 ± 0.91***
1000 95.83 ± 1.21
Galanthamine 500 93.58 ± 0.63 < 0.1
250 87.45 ± 0.90
125 83.08 ± 1.04
Result expressed as% inhibition (mean ± SEM of n = 3) and IC50 values. Values
significantly different as compare to positive control, *:P < 0.05, **:P < 0.01,
***:P < 0.001.
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ples to prevent the oxidation of ABTS to ABTS++ rad-
ical cation.
Phenolics are a class of antioxidant compounds which
function as free radical terminators [15]. Previous re-
ports indicate that the free radicals scavenging effi-
ciency of phenolics is dependent on their molecular
weight, presence of aromatic rings and nature of OH
group’s substitution [40]. Figure 1 shows extraction yieldof phenolics (mg GAE/g of sample) indicating that
Ph.EtAc, Ph.Chf and, Ph.Bt expressed high concentra-
tions of phenolics. Results of DPPH and ABTS scav-
enging activities well correlates with phenolic content
and might be attributed to presence of high molecular
phenolics in addition to flavonoids in these fractions
of plant. Median inhibitory values (IC50) were 3, 10,
15 and 35 μg/ml for Ph.Bt, Ph.Chf, Ph.EtAc and Ph.Sp
fractions in DPPH free radical scavenging assay. Likewise







Ph.Cr 1000 75.29 ± 0.64** 285
500 64.72 ± 0.89***
250 47.44 ± 0.86***
125 42.78 ± 0.45***
Ph.Hex 1000 90.30 ± 1.42 40
500 84.80 ± 0.41*
250 69.51 ± 0.59***
125 65.90 ± 0.32***
Ph.Chf 1000 85.94 ± 0.91* 215
500 62.93 ± 1.73***
250 51.82 ± 0.95***
125 46.68 ± 0.22***
Ph.EtAc 1000 81.01 ± 0.97** 395
500 59.05 ± 1.03***
250 34.54 ± 0.60***
125 29.88 ± 0.89***
Ph.Bt 1000 76.92 ± 1.15** 415
500 58.89 ± 1.73***
250 21.65 ± 2.41***
125 18. 20 ± 0.47***
Ph.Aq 1000 87.62 ± 1.42 3
500 84.79 ± 1.88
250 80.79 ± 1.08*
125 75.12 ± 0. 54**
Ph. Sp 1000 76.32 ± 0.87** 330
500 74.33 ± 0.66**
250 35.40 ± 0.82***
125 30. 90 ± 0.45***
Galantamine 1000 96.00 ± 0.30 < 0.1
500 92.90 ± 0.60
250 89.45 ± 0.90
125 86.23 ± 0.22
Result expressed as% inhibition cmean ± SEM of n = 3) and IC50 values. Values
significantly different as compare to positive control, *:P < 0.05, **:P < 0.01,
***:P < 0.001.
























Figure 3 IC50 values For antioxidant activity of Plant extracts
using DPPH assay.
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which are comparable to positive control galantamine
(IC50 < 0.01) Figure 3 and Table 1. Our findings indicate
that P. hydropiper is enriched with antioxidant com-
pounds and show its possible effectiveness in the man-
agement of free radicals induced disorders especially
neurodegenerative diseases.
Medicinal plants having therapeutic potential for the
treatment of neurodegenerative diseases like AD, Epi-
lepsy and Parkinsonism have been extensively explored,still there is a continuous search for new drugs like
galanthamine [24,41]. There are several reports which
specify the biological potential of plants as AChE inhibi-
tors in-vitro as well as memory enhancers in-vivo
[41,42]. Table 2 shows AChE inhibitory activity (%) and
IC50 values of the plant extracts. All fractions showed
concentration dependent AChE inhibitory activity. Re-
sults of the current study revealed that Ph.Hex was most
effective against AChE causing 87.49% enzyme inhibition
with IC50 35 μg/ml. Other fractions were also effective
at 1 mg/ml concentration. The concentrations of the
crude plant extracts that inhibited BChE activity by 50%
(IC50) are presented in the Table. Our results indicate
that P. hydropiper extracts are equally effective against
BChE. The strongest BChE inhibitory activities were ex-
hibited by Ph.Aq and Ph.Hex fractions, causing 87.62
and 90.30% inhibition with IC50 values of 3 and 40 μg/ml
respectively.
Conclusions
In the light of our findings, it can be concluded that most
fractions of our plant screened herein exhibited high anti-
oxidant potential and can be related to presence of high
molecular weight phenolics. The plant has also showed in-
hibitory activity against AChE & BChE enzymes in dose-
dependent way. This warrant further investigations to ex-
ploit the potential use of the bioactive compounds in the
treatment of neurodegenerative diseases. Further research
linked to the isolation of the bioactive compounds via
bioassay-guided isolation is in progress in our laboratory.
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